Back to companies
REVELATION BIOSCIENCES, INC.
REVBUSNASDAQPharmaceuticals & HealthcareREVELATION BIOSCIENCES, INC.
Revenue
—
FY2025
Operating income
-$9.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API